Cargando…

Silencing of the Ca(2+) Channel ORAI1 Improves the Multi-Systemic Phenotype of Tubular Aggregate Myopathy (TAM) and Stormorken Syndrome (STRMK) in Mice

Tubular aggregate myopathy (TAM) and Stormorken syndrome (STRMK) form a clinical continuum associating progressive muscle weakness with additional multi-systemic anomalies of the bones, skin, spleen, and platelets. TAM/STRMK arises from excessive extracellular Ca(2+) entry due to gain-of-function mu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silva-Rojas, Roberto, Pérez-Guàrdia, Laura, Lafabrie, Emma, Moulaert, David, Laporte, Jocelyn, Böhm, Johann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266658/ https://www.ncbi.nlm.nih.gov/pubmed/35805973 http://dx.doi.org/10.3390/ijms23136968

Ejemplares similares

Case Report: Novel STIM1 Gain-of-Function Mutation in a Patient With TAM/STRMK and Immunological Involvement
por: de la Fuente-Munoz, Eduardo, et al.
Publicado: (2022)

Voluntary wheel running mitigates disease in an Orai1 gain-of-function mouse model of tubular aggregate myopathy
por: O’Connor, Thomas N., et al.
Publicado: (2023)

STIM1/ORAI1 Loss-of-Function and Gain-of-Function Mutations Inversely Impact on SOCE and Calcium Homeostasis and Cause Multi-Systemic Mirror Diseases
por: Silva-Rojas, Roberto, et al.
Publicado: (2020)

Calcium Dyshomeostasis in Tubular Aggregate Myopathy
por: Lee, Jong-Mok, et al.
Publicado: (2016)

Tubular aggregate myopathy: a case report.
por: Kim, Na Rae, et al.
Publicado: (2003)

Muscle MR Imaging in Tubular Aggregate Myopathy
por: Beltrame, Valeria, et al.
Publicado: (2014)

Genetic defects are common in myopathies with tubular aggregates
por: Gang, Qiang, et al.
Publicado: (2021)

Stormorken syndrome or York platelet syndrome: A clinician's dilemma
por: Singh, Amrathlal Rabbind, et al.
Publicado: (2015)

CIC-39Na reverses the thrombocytopenia that characterizes tubular aggregate myopathy
por: Cordero-Sanchez, Celia, et al.
Publicado: (2022)

Stormorken Syndrome Caused by a Novel STIM1 Mutation: A Case Report
por: Jiang, Li-Jun, et al.
Publicado: (2021)

Stormorken syndrome caused by STIM1 mutation: A case report and literature review
por: Sun, Wenqiang, et al.
Publicado: (2022)

Muscle imaging in patients with tubular aggregate myopathy caused by mutations in STIM1
por: Tasca, Giorgio, et al.
Publicado: (2015)

DNM2 levels normalization improves muscle phenotypes of a novel mouse model for moderate centronuclear myopathy
por: de Carvalho Neves, Juliana, et al.
Publicado: (2023)

Tubular aggregate myopathy caused by a novel mutation in the cytoplasmic domain of STIM1
por: Okuma, Hidehiko, et al.
Publicado: (2016)

Luminal STIM1 Mutants that Cause Tubular Aggregate Myopathy Promote Autophagic Processes
por: Sallinger, Matthias, et al.
Publicado: (2020)

Ryanodine receptor 1 (RYR1) mutations in two patients with tubular aggregate myopathy
por: Vattemi, Gaetano Nicola Alfio, et al.
Publicado: (2022)

Mild Functional Differences of Dynamin 2 Mutations Associated to Centronuclear Myopathy and Charcot-Marie-Tooth Peripheral Neuropathy
por: Koutsopoulos, Olga S., et al.
Publicado: (2011)

A Premature Stop Codon in MYO18B is Associated with Severe Nemaline Myopathy with Cardiomyopathy
por: Malfatti, Edoardo, et al.
Publicado: (2015)

Muscle magnetic resonance characterization of STIM1 tubular aggregate myopathy using unsupervised learning
por: Lupi, Amalia, et al.
Publicado: (2023)

A dog model for centronuclear myopathy carrying the most common DNM2 mutation
por: Böhm, Johann, et al.
Publicado: (2022)

A dual mechanism promotes switching of the Stormorken STIM1 R304W mutant into the activated state
por: Fahrner, Marc, et al.
Publicado: (2018)

Centronuclear (myotubular) myopathy
por: Jungbluth, Heinz, et al.
Publicado: (2008)

Allele‐specific silencing therapy for Dynamin 2‐related dominant centronuclear myopathy
por: Trochet, Delphine, et al.
Publicado: (2017)

Case report of intrafamilial variability in autosomal recessive centronuclear myopathy associated to a novel BIN1 stop mutation
por: Böhm, Johann, et al.
Publicado: (2010)

A luminal EF-hand mutation in STIM1 in mice causes the clinical hallmarks of tubular aggregate myopathy
por: Cordero-Sanchez, Celia, et al.
Publicado: (2019)

Protein Aggregates and Aggrephagy in Myopathies
por: Gibertini, Sara, et al.
Publicado: (2023)

Stormorken Syndrome Caused by a p.R304W STIM1 Mutation: The First Italian Patient and a Review of the Literature
por: Borsani, Oscar, et al.
Publicado: (2018)

An Integrated Diagnosis Strategy for Congenital Myopathies
por: Böhm, Johann, et al.
Publicado: (2013)

Clinical, histological, and genetic characterization of PYROXD1-related myopathy
por: Lornage, Xavière, et al.
Publicado: (2019)

Similarities and Differences between the Orai1 Variants: Orai1α and Orai1β
por: Jardin, Isaac, et al.
Publicado: (2022)

Centronuclear myopathies under attack: A plethora of therapeutic targets
por: Tasfaout, Hichem, et al.
Publicado: (2018)

Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances
por: Gómez-Oca, Raquel, et al.
Publicado: (2021)

Altered Splicing of the BIN1 Muscle-Specific Exon in Humans and Dogs with Highly Progressive Centronuclear Myopathy
por: Böhm, Johann, et al.
Publicado: (2013)

TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting
por: Peeters, Marlies J. W., et al.
Publicado: (2019)

Orai channels: key players in Ca(2+) homeostasis
por: Sallinger, Matthias, et al.
Publicado: (2020)

Physiological impact and disease reversion for the severe form of centronuclear myopathy linked to dynamin
por: Muñoz, Xènia Massana, et al.
Publicado: (2020)

Correction: Altered Splicing of the BIN1 Muscle-Specific Exon in Humans and Dogs with Highly Progressive Centronuclear Myopathy
por: Böhm, Johann, et al.
Publicado: (2013)

MTM1 overexpression prevents and reverts BIN1-related centronuclear myopathy
por: Giraud, Quentin, et al.
Publicado: (2023)

Differential TAM receptor–ligand–phospholipid interactions delimit differential TAM bioactivities
por: Lew, Erin D, et al.
Publicado: (2014)

Some DNM2 mutations cause extremely severe congenital myopathy and phenocopy myotubular myopathy
por: Biancalana, Valérie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6iehiej4em4osmndpfo8u8inqm